Lohmann

LTS Lohmann Therapie-Systeme is a global leader in the development and manufacture of innovative drug delivery systems, specifically transdermal patches and oral thin films. As a premier CDMO, the company provides end-to-end services from formulation development and clinical trial supplies to large-scale commercial production. Their technology portfolio includes the proprietary Micro Array Patch (MAP) platform, designed for the transdermal delivery of large molecules, such as biologics and vaccines, which are traditionally administered via injection. LTS partners with leading pharmaceutical companies to bring complex drug-device combination products to market, enhancing patient adherence and therapeutic efficacy. Headquartered in Germany with a significant presence in the United States, LTS remains at the forefront of non-invasive drug delivery innovation.